# Levosimendan

## Simdax inj 12.5mg/5mL

##### 

| TAH Drug Code      | [ISIMD](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ISIMD)                                                                                                                                                                                                                                      |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Short-term treatment of acutely decompensated severe chronic heart failure (ADHF) wherein conventional therapy is not sufficient & in cases where inotropic support is appropriate.                                                                                                                         |
| Dosing             | For the short-term treatment of patients with acute decompensated heart failure when conventional therapies are insufficient and inotropic support is appropriate Adults: IV: Initial: 6 to 12 mcg/kg infused over 10 minutes. Maintenance: 0.05 to 0.1 mcg/kg/minute by continuous infusion for 24hr only. |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                    |
| Contraindications  | Hypersensitivity. Severe hypotension & tachycardia. Significant mechanical obstructions affecting ventricular filling or outflow or both. Severe renal impairment (CrCl <30 mL/min) & severe hepatic impairment. History of Torsades de Pointes, hypotension(SBP<100 mmHgæˆ–DBP<60 mmHg).                    |
| Adverse Effects    | Headache; ventricular tachycardia; hypotension. Hypokalaemia; insomnia; dizziness; atrial fibrillation, tachycardia, ventricular extrasystoles, cardiac failure, myocardial ischaemia, extrasystoles; nausea, constipation, diarrhoea, vomiting; decreased Hb.                                              |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                     |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                     |

